Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FW1LZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,738
Award facts
- Contract value 100% obligated
- $6,737.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,737.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for a critical medical commodity supporting federal healthcare requirements. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order exemplifies AmerisourceBergen's role within the DLA's pharmaceutical supply chain, fulfilling essential medication requirements for federal beneficiaries through the established indefinite delivery contract framework.
Quick answers
Who was awarded contract SPE2DB25FW1LZ?
SPE2DB25FW1LZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FW1LZ worth?
The government has obligated $6,738 on SPE2DB25FW1LZ.
Is contract SPE2DB25FW1LZ an order under another contract?
Yes. SPE2DB25FW1LZ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW1LZ competed?
The extent of competition for SPE2DB25FW1LZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award